This presentation will describe some of the technical difficulties in developing an appropriate method for this assay, as well as the prevalence of some of these compounds in the California medical market. Method validation work and long-term performance of the method will be discussed, as well as implications of existing and future regulations.
Key Learning Points
Requirements and challenges of Cannabis testing
LC-MS/MS method development and tips for overcoming high levels of matrix effects
Prevalence of chemical residues in CA medical market
Method performance assessment from validation parameters
Development of QA regulations for Cannabis
David Egerton, VP - Technical Operations, CW Analytical